Superparamagnetic iron oxide nanoparticles for direct labeling of stem cells and in vivo MRI tracking
Open Access
- 3 August 2015
- journal article
- research article
- Published by Wiley in Contrast Media & Molecular Imaging
- Vol. 11 (1), 55-64
- https://doi.org/10.1002/cmmi.1658
Abstract
To develop effective stem cell therapies, it is important to track therapeutic cells non‐invasively and monitor homing to areas of pathology. The purpose of this study was to 1 design and evaluate the labeling efficiency of commercially available dextran‐coated superparamagnetic iron oxide nanoparticles, FeraTrack Direct (FTD), in various stem and immune cells; 2 assess the cytotoxicity and tolerability of the FTD in stem cells; and 3 monitor stem cell homing using FTD‐labeled bone‐marrow‐derived mesenchymal stromal cells (BMSCs) and neural stem cells (NSCs) in a tumor model by in vivo MRI. BMSCs, NSCs, hematopoietic stem cells (HSCs), T‐lymphocytes, and monocytes were labeled effectively with FTD without the need for transfection agents, and Prussian blue (PB) staining and transmission electron microscopy (TEM) confirmed intracellular uptake of the agent. The viability, proliferation, and functionality of the labeled cells were minimally or not affected after labeling. When 106 FTD‐labeled BMSCs or NSCs were injected into C6 glioma bearing nude mice, the cells homing to the tumors were detected as hypointense regions within the tumor using 3 T clinical MRI up to 10 days post injection. Histological analysis confirmed the homing of injected cells to the tumor by the presence of PB positive cells that are not macrophages. Labeling of stem cells or immune cells with FTD was non‐toxic, and should facilitate the translation of this agent to clinical trials for evaluation of trafficking of cells by MRI. Copyright © 2015 John Wiley & Sons, Ltd.Keywords
Funding Information
- National Institutes of Health (intramural)
This publication has 45 references indexed in Scilit:
- Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imagingNature Medicine, 2012
- Stem cells as therapeutic vehicles for the treatment of high-grade gliomasNeuro-Oncology, 2011
- Stem Cell Based Cancer Gene TherapyMolecular Pharmaceutics, 2011
- Proliferative Neural Stem Cells Have High Endogenous ROS Levels that Regulate Self-Renewal and Neurogenesis in a PI3K/Akt-Dependant MannerCell Stem Cell, 2011
- In Vivo Transfer of Intracellular Labels from Locally Implanted Bone Marrow Stromal Cells to Resident Tissue MacrophagesPLOS ONE, 2009
- Optimization and Validation of FePro Cell Labeling MethodPLOS ONE, 2009
- Detection and quantification of magnetically labeled cells by cellular MRIEuropean Journal of Radiology, 2009
- Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?Kidney International, 2009
- In vivo labeling of adult neural progenitors for MRI with micron sized particles of iron oxide: Quantification of labeled cell phenotypeNeuroImage, 2009
- A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic nicheBlood, 2007